BioCryst
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
BCRX News
BioCryst Pharmaceuticals (BCRX) shares ended the last trading session 6.1% higher at $6.81. The jump came on an impressive volume with a higher-than-average num...
BioCryst, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tazeen Ahmad from Bank of America Securities reiterated a Buy...
BioCryst Pharmaceuticals (BCRX) has seen its stock price fluctuate over the past month, dropping 12%. Returns for the past three months show a steeper decline....
Analyst ratings
91%
of 11 ratingsMore BCRX News
Cantor Fitzgerald analyst Steve Seedhouse raised the firm’s price target on BioCryst (BCRX) to $26 from $24 and keeps an Overweight rating on the shares. BioCry...
Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on BioCryst. The associated price target remains the same with $30.00. Elevate Your Inve...
Jefferies analyst Maury Raycroft maintained a Buy rating on BioCryst today and set a price target of $15.00. Elevate Your Investing Strategy: Take advantage of...
Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on Astria Therapeutics and decreased the price target to $13.00 from $23.00. Elevate Your Inves...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on Tuesday agreed to acquire Astria Therapeutics, Inc. (NASDAQ:ATXS) for a mix of cash and stock. The deal represe...
BioCryst Pharmaceuticals (BCRX) has reached a deal to acquire biopharmaceutical company Astria Therapeutics (ATXS) for about $700 million in cash and stock. Thi...
(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX), on Tuesday announced it has entered into a definitive agreement to acquire Astria Therapeutics, Inc. (ATXS),...